Ipamorelin: What It Is, What the Research Says, and What You Need to Know
A selective growth hormone secretagogue known for its clean, targeted GH release
Last updated: May 1, 2026
Educational purposes only. The information on this page is for educational and research purposes only. It does not constitute medical advice, diagnosis, or treatment. Research peptides are not FDA-approved for human therapeutic use unless explicitly stated. Always consult a licensed healthcare provider before using any compound.
What Is Ipamorelin?
Ipamorelin is a synthetic pentapeptide (5 amino acid chain) that belongs to the growth hormone secretagogue family — compounds that stimulate GH release from the pituitary gland.
What distinguishes Ipamorelin from other GH secretagogues like GHRP-6 is its selectivity: it causes clean GH release without the significant cortisol, prolactin, or appetite-stimulating side effects common to other compounds in its class.
It is frequently studied in combination with CJC-1295 for a synergistic GH-releasing effect.
What Does the Research Say?
- Animal studies confirm Ipamorelin's selective GH release without significant cortisol or prolactin elevation.
- Research shows dose-dependent GH increases with good safety profile in animal models.
- Combination with CJC-1295 in studies shows synergistic GH release greater than either compound alone.
- Limited human clinical trial data available.
Research context: Animal studies showing positive effects do not guarantee the same results in humans. Human evidence strength varies significantly by peptide — see the Quick Stats sidebar for details.
Common Use Cases in Research
These reflect how researchers and research communities discuss this compound — not therapeutic recommendations.
- Growth hormone optimization research
- Post-workout recovery
- Sleep quality improvement
- Anti-aging protocols
How It Works (Mechanism of Action)
Mimics ghrelin and binds to the GH secretagogue receptor (GHSR) in the pituitary, triggering GH release. Unlike GHRP-6, it does not significantly elevate cortisol or prolactin.
Reported Benefits & Risks
Reported Benefits
Reported Risks
What People Ask
What makes Ipamorelin different from GHRP-6?
Ipamorelin is more selective — it stimulates GH release without the significant cortisol elevation, prolactin increase, or strong appetite stimulation seen with GHRP-6. This selectivity makes it a cleaner research tool.
Should Ipamorelin be taken before bed?
Many researchers time Ipamorelin to coincide with the body's natural nocturnal GH pulse. Taking it before sleep may align with and amplify this natural pattern, though optimal timing in humans remains unstudied.
Legal & Regulatory Status
Research Only
Research use only. Not FDA-approved for human use.
Research Suppliers
Affiliate link below — we may earn a commission if you purchase. This does not influence our research coverage.
View Ipamorelin Research Suppliers (affiliate link)